Background: Patients undergoing cardiac surgery are at risk of anemia from blood loss, inflammation, and red blood cell lysis, necessitating blood product utilization and increasing the risk of post-operative complications. RBT-1 (a combination of stannic protoporfin and iron sucrose) is a novel preconditioning drug administered prior to surgery that upregulates anti-inflammatory, antioxidant, and iron scavenging [...]